Types of grant

Bridging fellowships – OPEN

Opening: Wednesday 30th November 2022

Deadline: 16:00 Wednesday 25th January 2023

Funding decision: May 2023

Contact: Julie Marsden at awards@versusarthritis.org

This scheme has two funding rounds a year: one with a submission deadline in January with a decision in May and one with a submission deadline in July with a decision in November.

Our new bridging fellowship scheme will provide up to 2 years funding for current Versus Arthritis fellowship holders in the final year of their fellowship, irrespective of length of award. The aim of the fellowship is to provide fellows with additional financial support to bridge them to their next fellowship application or academic post, providing them with the opportunity to continue the development of an independent research career and progression towards higher-level appointments. Applications should be jointly submitted by the candidate with a sponsor.

Full details of the scheme and guidance documents are available here.

Orthopaedic Research UK/Versus Arthritis AI research fellowship in MSK - OPENING SOON

Versus Arthritis is partnering with Orthopaedic Research UK to provide MSK clinicians with an opportunity to enhance their knowledge and research skillset in AI, thereby enabling effective application of AI solutions within the NHS.

Two free training courses will be provided in partnership with Microsoft in January and April 2023.

Those that successfully complete both courses will be eligible to apply for the Fellowship in Spring 2023.

Further information regarding the Orthopaedic Research UK/Versus Arthritis AI Research Fellowship in MSK will be available soon. Please check this webpage for further updates.

To sign up for the first workshop, register at oruk.org

Career Development Fellowships – CLOSED

Opening: April 2023

Deadline: July 2023

Funding decision: 2024

Contact: Sydney Ambrose and Julie Marsden at awards@versusarthritis.org

Our new enhanced career development fellowship aims to attract and retain talented medical, veterinary, nurse and allied health professionals or science graduates committed to a research career in any discipline relevant to arthritis and related musculoskeletal diseases, and provide them with the opportunity to develop an independent research career and progress towards higher-level appointments. These fellowships offer five years of funding and applications should be jointly submitted by the candidate with a sponsor. Full details of the scheme and guidance documents are available here.

Starter Grants for Clinical Lecturers – CLOSED

Maximum duration: one to two years

Deadline: The next funding round is due to open in January 2023. Please check acmedsci.ac.uk for further details.

Contact: Academy of Medical Sciences grants team at clinicallecturers@acmedsci.ac.uk

This scheme is a partnership between the Academy of Medical Sciences and Versus Arthritis. Other partners in this scheme include the Wellcome Trust, the British Heart Foundation, the Medical Research Council and Diabetes UK.

What do starter grants for clinical lecturers provide?

The starter grants for clinical lecturers scheme provides modest starter funds of up to £30,000 over one to two years to enable research active clinical lecturers to pursue their research work, gather preliminary data and so further strengthen their applications for longer term fellowships and funding.

Who can apply for a starter grant for clinical lecturer?

The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.

All eligible applicants must:

  • Have a PhD or MD 
  • hold a medical, dental or veterinary undergraduate degree and be registered with the General Medical Council, General Dental Council or Royal College of Veterinary Surgeons 
  • hold a clinical contract.

What can you apply for?

The maximum grant available is £30,000. This can be spread over one to two years to contribute towards directly incurred research costs such as consumables and equipment.

Grants cannot be used to pay for your personal salary costs or to employ research assistants, PhD students or postdoctoral staff.

How to apply

These grants are administered by the Academy of Medical Sciences, more information and details on how to apply can be found at acmedsci.ac.uk.

During the review process, prior career breaks will be taken into account when evaluating a candidate’s research output and progress.

Successful applicants cannot reapply. Unsuccessful applicants are limited to one resubmission.

Priorities 2023: Accelerating diagnosis and treatment - CLOSED

Maximum Duration: 60 months

Costs: £50,000 to £800,000

Application Deadline: 16:00 Wednesday 9th November 2022

Contact: awards@versusarthritis.org

Focus

We want to bring about more accurate and faster diagnosis and more timely, effective and targeted treatments, tailored to individuals, taking into consideration not just their genes but also the environment they live in.

Our Better Lives Today, Better Lives Tomorrow Research Strategy 2022-2026 focusses our investment and influence on four priority areas over the next four years. It is striving to bring ground-breaking scientific discoveries to people with arthritis at pace and with precision.

This call for applications for research funding focusses on two of the priority areas:

  • Early detection and prevention: spotting the biological signatures of arthritis early to maximise the opportunities for timely intervention and preventing it from getting worse.
  • Targeted treatments: taking the guesswork out of treatment by increasing effective, reliable and timely drug and non-drug solutions to reduce, manage or cure disease.

What are we looking for?

The impacts sought from this investment are progress toward:

  • better understanding and tools to identify markers of risk to enable proactive screening and early detection (secondary prevention) approaches
  • better tools and biomarkers to diagnose arthritis accurately and as rapidly as possible after symptoms begin
  • clinical and care pathways applying a precision medicine and holistic approach – accounting for individual variability in genes, environment and lifestyle and the management of pain, mental health and fatigue
  • more effective, safer treatments and ultimately cures, that work for more people
  • better tools to help decide the most appropriate treatments
  • better understanding of how different diseases can be most effectively tackled together.

Who can apply?

  • The lead applicant must be based at an eligible UK institution.
  • One applicant must have a tenured position within the lead institute.

For further information see the Priorities 2023: Application Guidance (PDF, 279KB).

What you can apply for

  • Costs for salaries, expenses and small items of essential equipment can be requested.
  • Awards of up to 60 months duration, between £50,000-£800,000 in value are available. We plan to invest around £4 million in different sized projects.

For further details on what you can apply for see the Priorities 2023: Application Guidance (PDF, 279KB).

How to apply

Applicants are invited to submit applications through Grant Tracker, where the form is available.

There is a single stage application process for all applications.

Applicants must carefully read the Priorities 2023: Call Document (PDF, 200KB), application form and Priorities 2023: Application Guidance (PDF, 279KB) before starting an application.

Please ensure that the most appropriate language is being used in each section of the form and that the correct sections are completed.

The deadline for the receipt of applications in 16:00 on Wednesday the 9th of November 2022. Please allow time for management of appropriate reviewers and signatories to access the GrantTracker system and provide their approvals. Submissions after 16:00 will not be accepted.

If you have any questions about the call please email awards@versusarthritis.org

Fatigue evidence review 2023 - CLOSED

We have partnered with the Kennedy Trust for Rheumatology Research to increase the evidence around fatigue in musculoskeletal conditions.

Maximum Duration: 12 months

Costs: £100,000

Application Deadline: 16:00 Monday 7 November 2022

Contact: awards@versusarthritis.org  

Focus

We are looking to fund a single proposal that can generate a substantial and well-evidenced scoping review that comprehensively covers how chronic fatigue is measured, assessed, and treated. Reviews should include scientific and clinical evidence, as well as meaningful inclusion of the needs of people living with chronic fatigue.

We expect the primary focus of the review to be on musculoskeletal fatigue, but encourage cross-disease applications, including outside musculoskeletal diseases where chronic fatigue is a key component. We welcome proposals that include Chronic Fatigue Syndrome (CFS) /ME in the analysis, but proposals that include CFS/ME as the primary focus will not be reviewed. Studies that also include COVID-19 in the analysis will be accepted. We strongly encourage applications that carefully consider chronic fatigue across the life course (younger to older) and across diverse demographics and ethnic groups.

There is an expectation that applicants meaningfully involve people living with chronic fatigue in the development of the outlined work.

What are we looking for?

We aim to fund a comprehensive scoping review on the ways of measuring, assessing, and treating chronic fatigue. This can include:

  • the amount of evidence in each area
  • the quality of evidence available
  • where there are substantial gaps in our current knowledge
  • the needs of people living with chronic fatigue
  • future research priorities based on the information gathered

The outputs of this scoping review are expected to provide an important guide and inform future research partnership activity.

Applicants must carefully read the application form and guidance documentation before starting an application. Please ensure that the most appropriate language is being used in each section of the form and that the correct sections are completed.

Who can apply?

What you can apply for

  • Costs for salaries, expenses and essential research costs can be requested.
  • One award of up to 12 months duration, £100,000 in value is available.
  • For further details on what you can apply for, please see Fatigue evidence review 2023 Application Guidance (PDF, 208KB).

How to apply

Applicants are invited to submit applications through Grant Tracker, where the form is available.

There is a single-stage application process for all applications.

Applicants must carefully read the Fatigue evidence review 2023 Call Document (PDF, 196 KB), application form and Fatigue evidence review 2023 Application Guidance (PDF, 208KB) before starting an application.

Please ensure that the most appropriate language is being used in each section of the form and that the correct sections are completed.

The deadline for the receipt of applications is 16:00 on Monday the 7 November 2022. Please allow time for the management of appropriate reviewers and signatories to access the GrantTracker system and provide their approvals. Submissions after 16:00 will not be accepted.

If you have any questions about the call, please email awards@versusarthritis.org

Oliver Bird Fund - CLOSED

Outline deadline: 14 March 2022

Invited full application deadline: July 2022

Contact: applications@nuffieldfoundation.org

We have partnered with the Nuffield Foundation for the next Oliver Bird Fund (OBF) initiative. The broad goal of the Fund is to improve the lives of those living with musculoskeletal (MSK) conditions and the new joint call will focus on biopsychosocial approaches to generate new knowledge to support policy- and practice-led improvements for people with musculoskeletal conditions.

The significance of this call to people living with MSK conditions has been clearly articulated in a blog co-written by Colin Wilkinson, a Versus Arthritis Research Partner.

Applications focused on the following areas will be considered; participation in education, training work; economic security; supporting mental health; and socio-economic inequalities that increase the risk of poorer outcomes for people with MSK.

Interdisciplinary approaches, as well as applicants from wider fields as well as those with musculoskeletal expertise, are particularly welcome to apply.

For full information on how to apply for this funding, please see the Oliver Bird Fund website.

Nurse and allied health professional internship scheme - CLOSED

Opening: 8 December 2021

Contact: Mary Fry (m.l.fry@soton.ac.uk)

What do the internships provide?

This internship scheme is open to recent graduates (within 5 years) or final year students in an AHP profession (HCPC registerable) or Nursing with either a predicted or a first or 2:1 degree who have an interest in clinical research into the personal impact of arthritis and musculoskeletal diseases. The internships are for eight weeks full-time equivalent with the core dates covering July and August but flexible and part-time options are available. They provide opportunities to gain research experience working alongside some of the UK’s leading nurse and allied health researchers.

Full details of the Nurse and allied health professional internship scheme are available here.

MRC/ESRC/BBSRC-Versus Arthritis Advanced Pain Discovery Platform – Mapping the complexity of pain – CLOSED

As part of the Advanced Pain Discovery Platform (APDP) initiative we are launching a call for research projects focused on increasing the understanding of the underlying mechanisms of pain. The call is funded as a partnership between UKRI, Versus Arthritis, the Medical Research Foundation and Eli Lilly, and a joint investment of up to £10.5 million is available.

What are we looking for?

Projects can seek to explore mechanisms of pain in various disciplines, including psychological, biological, cognitive and sociological aspects. Where possible within the scope of the research question, researchers are encouraged to work together across disciplines to facilitate novel research into the underlying mechanisms of pain. Each proposal may focus on a specific pain condition, or a specific aspect of pain, or they may span conditions. We expect to support pre-clinical as well as clinical research projects, with a focus on understanding the mechanisms of pain. All projects must demonstrate a clear pathway to impact for people with lived experience of chronic pain.

Proposals focusing on musculoskeletal conditions in both adults and children are encouraged. Through the involvement of the Medical Research Foundation, part of the available budget (up to £3.5 million) has been ring-fenced for funding of research into mechanisms of pain in children or adolescents, with a particular, but not sole, focus on musculoskeletal conditions in this group. Applications seeking to increase our understanding of the transition from acute to chronic pain, changes in the experience of pain, and/or the transition to remission are also encouraged.

Proposals may involve a wide range of methodology across disciplines, and applications involving the use of AI, machine learning and other innovative data technologies are particularly encouraged.

Links with other APDP initiatives

The research funded through this call will be expected to work with the recently established APDP Consortia and Alleviate – the APDP Pain Research Data Hub, to share information, and identify and exploit synergies between research disciplines and conditions. Funded applicants will be incorporated into the APDP through an engagement platform and networking activities to enhance collaboration and co-ordination across the UK pain research community. Applicants do not need any link to the APDP Consortia or Data Hub prior to applying. Applicants are, however, encouraged to explore opportunities for strategic alignment with the Consortia where scientific overlap exists. Applicants should make contact with the Data Hub prior to applying to understand expectations on data gathering, management and integration into the hub to advance the aims of the APDP.

Who can apply?

You must be a UK research organisation eligible for Medical Research Council funding. This includes:

  • higher education institutions
  • eligible independent research organisations
  • eligible public sector research establishments
  • eligible NHS bodies
  • research council institutes.

Please see the MRC guidance for applicants for further information on institutional and individual eligibility. Early and mid-career researchers are strongly encouraged to apply.

Your proposal must show:

  • research questions focused on the mechanisms of pain
  • appropriate involvement of people with lived experience of chronic pain embedded across all stages
  • how the proposal will integrate into the Advanced Pain Discovery Platform (APDP).

What can be applied for?

The call will support a broad portfolio of research projects ranging from smaller, more focussed grants to larger research grants. Funding can be sought for a maximum of three years and we do not expect to support grants above £1 million. Grants will be funded at 67% Full Economic Cost.

How to apply

This call is being administered through UKRI and full information on the application process can be found on the UK Research and Innovation webpage.

Anyone planning to submit an application to this call should email an intention to submit form found on the UKRI webpage to spfpain@mrc.ukri.org by 4.00 pm, 15 July 2021. This is mandatory and proposals will not be accepted from applicants who have failed to complete an intention to submit.

Please include the names of the principal investigator, potential co-investigators and any collaborating organisations confirmed at this stage. This is to help us prepare for peer review and manage conflicts at the panel assessment stage and will not be assessed in any way.

The full proposal should be submitted through the UKRI grant management system Je-S by 4.00 pm, 15 September 2021.

Contact

For more information on this call please see the UKRI funding page. If you have any queries on the call please email spfpain@mrc.ukri.org or the Versus Arthritis contact: Clare Farmer at research@versusarthritis.org.

Connect Immune Research - Chernajovsky Foundation Targeting Shared Mechanisms in Immune Mediated Inflammatory diseases - CLOSED

Summary

The Connect Immune Research Partnership are collaborating with The Lorna & Yuti Chernajovsky Biomedical Research Foundation to offer a new competitive funding opportunity focused on developing new treatments for autoimmune and immune-mediated inflammatory diseases. The scheme aims to support translational research by multi-disciplinary teams that both ‘connect’ immune researchers and immune conditions, for the benefit of those living with autoimmune diseases.

Call information

Applications are invited from research teams affiliated to a university, hospital, or other recognised research institution worldwide, but the lead applicant must be based at a UK institution.

Proposals should be

  • Highly innovative, potentially risky research ideas are expected.
  • Translational research only, defined here as: Research that seeks to advance and apply discoveries from basic discovery research and/or clinical findings, through preclinical studies and towards clinical studies and trials. Development of drugs, diagnostics and devices are welcomed.
  • Able to demonstrate how the outputs from the award could lead to benefit for patients from more than one autoimmune condition.

How to apply

This call is being administered by Versus Arthritis on behalf of the Connect Immune Partners and the Chernajovsky Foundation.

Full details of the scheme and the guidance document for how to make an application are available here:

Connect Immune Research / Chernajovsky Foundation. Targeting shared mechanisms in immune mediated inflammatory diseases, guidance for funding applications (PDF, 296 KB).
Call for applications: Targeting shared mechanisms in immune-mediated inflammatory diseases (PDF, 234 KB).

Submission deadline is 4.00 pm on Wednesday 13 October 2021.

What can be applied for?

The award will be for up to £100,000, up to 12 months with an expected starting date by Spring 2022.

The total amount of funding available for this Call will be £1.3M which is intended to be used to fund up to thirteen successful applications.

Funding decisions are anticipated by February 2022.

It is envisaged that successful candidates whose projects demonstrate the most promising outputs will be able to compete for further funding at a scale to quickly develop their research for patient benefit.

Contact

For more information on this call please email: research@versusarthritis.org.

The Connect Immune Research member organisations are: Alopecia UK, Bowel Research UK, the British Society for Immunology, Coeliac UK, JDRF, the MS Society, the Psoriasis & Psoriatic Arthritis Alliance (PAPAA) and Versus Arthritis.

Quality improvement in rheumatology practice: Delivering change for patients – CLOSED

Summary

We are collaborating with Pfizer UK to offer a new competitive funding opportunity focused on improving patient care and outcomes in rheumatology.

Call information

Applications are invited from UK health care organisations for a Quality Improvement Grant to support ‘’Quality Improvement in Rheumatology Practice: Delivering Change for Patients’’.

Proposals should address gaps in the appropriate management of one or more of:

We are particularly interested in proposals that:

  • Focus on the improvement of patient care, patient experience and improved outcomes aiming at systematic and continuous actions that lead to measurable improvement in health care services and the health status of individuals and targeted patient groups in rheumatology.
  • Improve services and pathways for people with chronic inflammatory arthritis conditions with the aim of improving people’s quality of life, ability to self-manage (such as self-efficacy, patient activation), co-morbidities, and overall patient experience.
  • Proposals which will have the highest chance of making a difference to the lives of people with arthritis.

Proposals for projects covering the following areas are out of scope of this call:

  • Clinical research projects.
  • Projects evaluating the efficacy of therapeutic or diagnostic agents.

During review the intended outcome of the project and translation into the NHS to benefit patients will be given careful consideration. Any patient involvement or patient input into any stage of the project should be outlined clearly.

How to apply

These grants are administered by Pfizer UK, more information and details on how to apply can be found at www.pfizer.co.uk.

Submission deadline is Monday 7 June 2021.

The total amount of funding available for this Call will be £216,000 which is intended to be used to fund up to four successful applications.

Grant applications will be reviewed by an expert review panel (ERP) to make final grant decisions. The ERP is comprised of patients with lived experience of arthritis, professionals from the medical community with advanced degrees and expertise in particular clinical areas, or specific needs of a geographic region/learner group, or expertise in research, continuing professional development or quality improvement. Funding decisions are anticipated by August 2021.

MRC/ESRC/BBSRC-Versus Arthritis Advanced Pain Discovery Platform – Pain Research Data Hub - CLOSED

Summary

As part of the UKRI/Versus Arthritis Advanced Pain Discovery Platform (APDP) initiative we are launching a call for proposals to establish a national data hub for pain research in partnership with Health Data Research UK.

The purpose of the hub is to bring together and curate health data from the NHS, social care and research (academic and industry) to provide innovative new high value data resources for pain research and innovation. The hub investment will serve to underpin original research rather than support it directly and will be embedded within the broader infrastructure and network of Health Data Research UK.

This call is being administered through UKRI and will support the funding of one hub for 3 years. Up to £2m UKRI contribution at 67% Full Economic Cost (FEC) is available.

For full information on this call including the hub specification please visit the UKRI funding page.

Who can apply

You must be a UK research organisation eligible for Medical Research Council funding. This includes:

  • higher education institutions
  • approved independent research organisations
  • approved NHS bodies
  • research council institutes.

Please see the MRC guidance for applicants for further information on institutional and individual eligibility.

Applications must be able to demonstrate appropriate scientific and clinical leadership, a track record of the use of health data for public benefit, and the ability to process health data for research and innovation. The hub must deliver a national service that will be financially sustainable in the long-term.

Recognising the value of regional data sets and leadership it is expected that proposals involve multi-institutional collaboration. However, proposals must be submitted by a single lead organisation.

Institutions may be partners to more than one application but should only act as lead institution for one.

At least one member of the partnership must have a demonstrable track record in acting as a data custodian with the ability to make data accessible for research, development and innovation taking place across academia, industry and the NHS.

We strongly encourage collaboration across sectors, including NHS organisations, academia, industry and other partners. You can also include international co-investigators if they provide expertise that is not available in the UK. We expect strong commitment to patient involvement in the development and implementation of the data hub.

How to apply

If you are intending to apply to this call please email the expression of interest form found on the UKRI website to spfpain@mrc.ukri.org by 16:00 29 January 2021. Please include the names of the PI, Co-Is and any collaborating organisations confirmed at this stage. This is to help us manage conflicts at the panel assessment stage and will not involve any assessment at this stage.

This is a single stage call and a full proposal should be submitted through the UKRI Je-S system by 16:00 25 February 2021.

If you have any queries on the call please email spfpain@mrc.ukri.org or the Versus Arthritis contact: Clare Farmer at research@versusarthritis.org.

MRC/ESRC/BBSRC-Versus Arthritis Advanced Pain Discovery Platform – Multidisciplinary Consortia for Data Generation – CLOSED

Versus Arthritis in partnership with the Medical Research Council (MRC), Economic and Social Research Council (ESRC) and Biotechnology and Biological Sciences Research Council (BBSRC) are pleased to announce the launch of a £14m call for large and ambitious multidisciplinary consortia.

This will build the foundation of a national-scale programme supporting discovery and translational science that will bring together leadership, tools, and resources to help unravel the complexity of pain, driving new treatment development. This investment is part of a major new £24m initiative to establish an Advanced Pain Discovery Platform that is jointly supported by the UKRI Strategic Priorities Fund and Versus Arthritis and will lead to step changes in the understanding and treatment of chronic pain across a wide range of conditions.

The call will make £14m available through 4-year awards to fund high impact, multidisciplinary consortia that will bring together researchers across the breadth of biomedical, social, and data sciences. The consortia are expected to establish enduring national-scale leadership, infrastructure and capability that extends beyond the initial 4-year award. They will serve to underpin a future broader portfolio of pain research supported by UKRI, Versus Arthritis and others, and should collaborate with each other to ensure added value from the Advanced Pain Discovery Platform. It is expected that the consortia will embrace complementary access to patients, healthy volunteers and underpinning technology. Areas of focus could include; multi-omic biology, image data generation, cognitive and psychosocial factor identification, exploiting existing biological samples and data and new sample/data collections. We expect that this programme of work will support 3-5 consortia.

Call information

The call will provide funding for collaborative multidisciplinary consortia that will focus on:

  • Pursuing innovative and ambitious “big ideas” in chronic pain research, which will enable a step change in the field.
  • Improving our understanding of the mechanisms of pain, building on our knowledge of normal pain processes to better understand chronic pain, taking into account biological, cognitive and psychosocial factors.
  • Collating, generating and interrogating human data and samples, to allow for the identification and validation of new interventions, and to allow improved access to well-phenotyped human populations.

Each application should demonstrate how it will:

  • Actively strengthen intersections between important disciplines that do not routinely engage with each other.
  • Build capacity in the field and develop skills.
  • Embed knowledge mobilisation.
  • Involve patient insight in the development of the outlined work as well as collaborate with them in the delivery of the proposed research.

It is expected that successful consortia will focus on chronic pain, however applications may be focussed on specific pain-related disorders or may consider common mechanisms underlying multiple pain conditions.

This initial call includes, but is not limited to, key staff posts and infrastructure costs, data collection and access, sample storage and sample analysis, with an emphasis on data and samples for patients and healthy volunteers. As these consortia will be co-funded between Versus Arthritis and UKRI, awards will be made at 67% fEC.

As part of this Advanced Pain Discovery Platform initiative, a second phase of complementary calls will be launched in the near future for hypothesis-led research projects (with the foci of these being either generated from within, or aligned to the successful consortia), a data management platform, and bioinformatics projects.

Process

The funding call will be in two stages:

1. Expression of Interest

To participate in this call for consortia, you must submit an Expression of Interest to MRC-UKRI via a bespoke online submission system by 31st of August 2020. You can find the online submission system on the MRC-UKRI call page which can be accessed here. On the MRC-UKRI call page you can also find additional guidance on the call and how to complete the Expression of Interest form. The purpose of the Expression of Interest phase is to enable selection of the highest quality applications, and those that are likely to develop into competitive full proposals. Decisions on Expressions of Interest will be made in October 2020. The potential impact of the COVID-19 pandemic on the preparation of Expressions of Interest is recognised by the funders, and it is anticipated that details of workstreams and consortium partners might evolve between selection and submissions of full application.

2. Full application

Shortlisted Expression of Interest applications will be invited to submit a full application by January 2021. Guidance on how to make the full submission will be provided to successful Expression of Interest applicants. Applicants will be invited to be interviewed by a bespoke panel of experts as part of the funding decision.

For full information on this call please visit the UKRI funding page.

If you have any queries on the call please email spfpain@mrc.ukri.org or the Versus Arthritis contact: Clare Farmer at research@versusarthritis.org.

Medical Technologies PoC Funding Call - CLOSED

Maximum duration: up to 2 years

Maximum costs: £100,000

Deadline: 30 June 2020

Contact: Mandy Wilkes at research@versusarthritis.org or Graeme Howling at G.Howling@leeds.ac.uk

What does Medical Technologies Proof of Concept fund provide?

Funding is intended to develop or evaluate innovative technologies that help support individuals suffering with musculoskeletal conditions; in particular projects that develop the following:

  • Medical devices
  • Orthotics
  • Implantable therapeutic delivery
  • Imaging

Who can apply for funding?

Any academic, clinician and allied health care professional at a UK institution.

Collaborations with industry are strongly encouraged.

What can you apply for?

Maximum support that can be requested is £100,000

Salaries

Requested salary costs should be based on a recognised pay model or the host institution’s local salary scale, including London weighting if appropriate. We must be advised of the pay model used and, where a local pay model is to be applied, a copy of the appropriate scale must be sent with the application. Annual increments must be included which should be based on the host institution’s own salary scale, including London weighting if appropriate.

Other

Those interested in learning more about the call are encouraged to read the Medical Technologies Proof of Concept Award call document (PDF, 213 KB).

How to apply

Expression of Interest applications should be submitted by 5.00 pm 30 June 2020 via Grant Tracker.